Patterns of Prescription of Antidepressants and Antipsychotics Across and Within Pregnancies in a Population-Based UK Cohort

Maternal and Child Health Journal

Volumn 18, Issue 7, 2014, Pages 1742-1752

  Margulis, Andrea V ^a   Kang, Elizabeth M ^a   Hammad, Tarek A ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Antidepressants; Antipsychotics; Clinical Practice Research Datalink; Drug utilization; Longitudinal; Pregnancy

Indexed keywords

EID: 84890903389     PISSN: 10927875     EISSN: 15736628     Source Type: Journal    
DOI: 10.1007/s10995-013-1419-2     Document Type: Article

References (25)

1. Bakker, M. K., Jentink, J., Vroom, F., Van Den Berg, P. B., & De Walle, H. E. (2006). De Jong-Van Den Berg LT. Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands. BJOG,113, 559–568. doi:10.1111/j.1471-0528.2006.00927.x.
2. Lacroix, I., Hurault, C., Sarramon, M. F., Guitard, C., Berrebi, A., Grau, M., et al. (2009). Prescription of drugs during pregnancy: A study using EFEMERIS, the new French database. European Journal of Clinical Pharmacology,65, 839–846. doi:10.1007/s00228-009-0647-2.
3. Gagne, J. J., Maio, V., Berghella, V., Louis, D. Z., & Gonnella, J. S. (2008). Prescription drug use during pregnancy: A population-based study in Regione Emilia-Romagna. Italy. European Journal of Clinical Pharmacology,64, 1125–1132. doi:10.1007/s00228-008-0546-y.
4. Mitchell, A. A., Gilboa, S. M., Werler, M. M., Kelley, K. E., Louik, C., & Hernandez-Diaz, S. (2011). Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. American Journal of Obstetrics and Gynecology,205(51), e1–e8. doi:10.1016/j.ajog.2011.02.029.
5. Epstein, R. A., Bobo, W. V., Shelton, R. C., Arbogast, P. G., Morrow, J. A., Wang, W., et al. (2012). Increasing use of atypical antipsychotics and anticonvulsants during pregnancy. Pharmacoepidemiology and Drug Safety,. doi:10.1002/pds.3366.
6. Ververs, T., Kaasenbrood, H., Visser, G., Schobben, F., den Berg, L., & Egberts, T. (2006). Prevalence and patterns of antidepressant drug use during pregnancy. European Journal of Clinical Pharmacology,62, 863–870. doi:10.1007/s00228-006-0177-0.
7. Petersen, I., Gilbert, R. E., Evans, S. J., Man, S. L., & Nazareth, I. (2011). Pregnancy as a major determinant for discontinuation of antidepressants: An analysis of data from The Health Improvement Network. Journal of Clinical Psychiatry,72, 979–985. doi:10.4088/JCP.10m06090blu.
8. Colvin, L., Slack-Smith, L., Stanley, F. J., & Bower, C. (2011). Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy. Birth Defects Research Part A: Clinical and Molecular Teratology,91, 142–152. doi:10.1002/bdra.20773.
9. Charlton, R. A., Weil, J. G., Cunnington, M. C., Ray, S., & de Vries, C. S. (2011). Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: Anticonvulsants and the risk of major congenital malformations. Drug Safety,34, 157–171. doi:10.2165/11584970-000000000-00000.
10. Palmsten, K., Setoguchi, S., Margulis, A. V., Patrick, A. R., & Hernandez-Diaz, S. (2012). Elevated risk of preeclampsia in pregnant women with depression: Depression or antidepressants? American Journal of Epidemiology,175, 988–997. doi:10.1093/aje/kwr394.
11. General Practice Research Database. (2011). http://www.gprd.com/home/. Accessed October 25, 2011.
12. Charlton, R. A., Cunnington, M. C., de Vries, C. S., & Weil, J. G. (2008). Data resources for investigating drug exposure during pregnancy and associated outcomes: The General Practice Research Database (GPRD) as an alternative to pregnancy registries. Drug Safety,31, 39–51.
13. Mother Baby Link Documentation. (2010). London: Medicines and Healthcare Products Regulatory Agency; GPRD Group July 2010.
14. Hammad, T. A., Margulis, A. V., Ding, Y., Strazzeri, M. M., & Epperly, H. (2013). Determining the predictive value of Read codes to identify congenital cardiac malformations in the UK Clinical Practice Research Datalink. Pharmacoepidemiology and Drug Safety,. doi:10.1002/pds.3511.
15. General Practice Research Database Practice Patient Populations. (2011). http://www.gprd.com/_docs/GPRD%20Practice%20Patient%20Populations%20Oct2011.pdf. Accessed November 29, 2011.
16. Reis, M., & Kallen, B. (2008). Maternal use of antipsychotics in early pregnancy and delivery outcome. Journal of Clinical Psychopharmacology,28, 279–288. doi:10.1097/JCP.0b013e318172b8d5.
17. Andrade, S. E., Gurwitz, J. H., Davis, R. L., Chan, K. A., Finkelstein, J. A., Fortman, K., et al. (2004). Prescription drug use in pregnancy. American Journal of Obstetrics and Gynecology,191, 398–407. doi:10.1016/j.ajog.2004.04.025.
18. Cooper, W. O., Willy, M. E., Pont, S. J., & Ray, W. A. (2007). Increasing use of antidepressants in pregnancy. American Journal of Obstetrics and Gynecology,196(544), e1–e5. doi:10.1016/j.ajog.2007.01.033.
19. Toh, S., Li, Q., Cheetham, T. C., Cooper, W. O., Davis, R. L., Dublin, S., et al. (2013). Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: A population-based study of 585,615 deliveries. Archives Womens Mental Health,16, 149–157. doi:10.1007/s00737-013-0330-6.
20. Suissa, S., Blais, L., & Ernst, P. (1994). Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma. European Respiratory Journal,7, 1602–1609.
21. Hall, G. C., McMahon, A. D., Carroll, D., & Home, P. D. (2012). Macrovascular and microvascular outcomes after beginning of insulin versus additional oral glucose-lowering therapy in people with type 2 diabetes: An observational study. Pharmacoepidemiology and Drug Safety,21, 305–313. doi:10.1002/pds.2345.
22. Walker, A. M., Koro, C. E., & Landon, J. (2008). Coronary heart disease outcomes in patients receiving antidiabetic agents in the PharMetrics database 2000-2007. Pharmacoepidemiology and Drug Safety,17, 760–768. doi:10.1002/pds.1598.
23. Jick, H., Jick, S. S., & Derby, L. E. (1991). Validation of Information Recorded on General-Practitioner Based Computerized Data Resource in the United-Kingdom. BMJ,302, 766–768.
24. Langley, T. E., Szatkowski, L., Gibson, J., Huang, Y., McNeill, A., Coleman, T., et al. (2010). Validation of The Health Improvement Network (THIN) primary care database for monitoring prescriptions for smoking cessation medications. Pharmacoepidemiology and Drug Safety,19, 586–590. doi:10.1002/pds.1960.
25. Li, Q., Andrade, S. E., Cooper, W. O., Davis, R. L., Dublin, S., Hammad, T. A., et al. (2013). Validation of an algorithm to estimate gestational age in electronic health plan databases. Pharmacoepidemiology and Drug Safety,. doi:10.1002/pds.3407.